Best NG - Search Results

1

Blood cyclosporine concentrations and cytomegalovirus infection following heart transplantation.

Best NG, Trull AK, Tan KK, Spiegelhalter DJ, Wreghitt TG, Wallwork J. Best NG, et al. Transplantation. 1995 Oct 15;60(7):689-94. doi: 10.1097/00007890-199510150-00013. Transplantation. 1995. PMID: 7570978 Clinical Trial.

2

Blood cyclosporin concentrations and the short-term risk of lung rejection following heart-lung transplantation.

Best NG, Trull AK, Tan KK, Hue KL, Spiegelhalter DJ, Gore SM, Wallwork J. Best NG, et al. Br J Clin Pharmacol. 1992 Dec;34(6):513-20. doi: 10.1111/j.1365-2125.1992.tb05657.x. Br J Clin Pharmacol. 1992. PMID: 1493084 Free PMC article.

3

Blood cyclosporin concentrations but not doses correlate with acute changes in renal function following heart and heart-lung transplantation.

Trull AK, Best NG, Tan KK, Hue KL, Higenbottam TW, Large S, Wallwork J. Trull AK, et al. Among authors: best ng. Ther Drug Monit. 1992 Aug;14(4):275-80. doi: 10.1097/00007691-199208000-00003. Ther Drug Monit. 1992. PMID: 1519300

4

Design and evaluation of a computer tool to aid early management of cyclosporine therapy after heart and heart-lung transplantation.

Best NG, Tan KK, Trull AK, Spiegelhalter DJ, Hue KL, Caine N, Wallwork J. Best NG, et al. Transplant Proc. 1994 Oct;26(5):2716-7. Transplant Proc. 1994. PMID: 7940850 No abstract available.

5

Pharmacokinetics of cyclosporine in heart and lung transplant candidates and recipients with cystic fibrosis and Eisenmenger's syndrome.

Tan KK, Trull AK, Hue KL, Best NG, Wallwork J, Higenbottam TW. Tan KK, et al. Among authors: best ng. Clin Pharmacol Ther. 1993 May;53(5):544-54. doi: 10.1038/clpt.1993.68. Clin Pharmacol Ther. 1993. PMID: 8491066

6

Estimation of population pharmacokinetics using the Gibbs sampler.

Best NG, Tan KK, Gilks WR, Spiegelhalter DJ. Best NG, et al. J Pharmacokinet Biopharm. 1995 Aug;23(4):407-35. doi: 10.1007/BF02353641. J Pharmacokinet Biopharm. 1995. PMID: 8882748

7

Pharmacodynamics of cyclosporine in heart and heart-lung transplant recipients. I: Blood cyclosporine concentrations and other risk factors for cardiac allograft rejection.

Best NG, Trull AK, Tan KK, Spiegelhalter DJ, Cary N, Wallwork J. Best NG, et al. Transplantation. 1996 Nov 27;62(10):1429-35. doi: 10.1097/00007890-199611270-00009. Transplantation. 1996. PMID: 8958268

8

Pharmacodynamics of cyclosporine in heart and heart-lung transplant recipients. II: Blood cyclosporine concentrations and other risk factors for lung allograft rejection.

Best NG, Tan KK, Trull AK, Spiegelhalter DJ, Stewart S, Wallwork J. Best NG, et al. Transplantation. 1996 Nov 27;62(10):1436-41. doi: 10.1097/00007890-199611270-00010. Transplantation. 1996. PMID: 8958269

9

Bayesian analysis of population PK/PD models: general concepts and software.

Lunn DJ, Best N, Thomas A, Wakefield J, Spiegelhalter D. Lunn DJ, et al. J Pharmacokinet Pharmacodyn. 2002 Jun;29(3):271-307. doi: 10.1023/a:1020206907668. J Pharmacokinet Pharmacodyn. 2002. PMID: 12449499

10

Combining MCMC with 'sequential' PKPD modelling.

Lunn D, Best N, Spiegelhalter D, Graham G, Neuenschwander B. Lunn D, et al. J Pharmacokinet Pharmacodyn. 2009 Feb;36(1):19-38. doi: 10.1007/s10928-008-9109-1. Epub 2009 Jan 9. J Pharmacokinet Pharmacodyn. 2009. PMID: 19132515 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Search Page

Filters